Mycofenolatmofetil Actavis (mycophenolate mofetil) is the generic equivalent of Roche’s Cellcept, and is used with other medicines to lower the body’s immunity after heart, kidney or liver transplant.
Mycofenolatmofetil Actavis is available in 500mg tablets or 250mg capsules.
Actavis has already launched the product in Bulgaria, Iceland, Norway, Portugal, Romania and Slovakia, where no patent was in place.
Iceland-based Actavis develops, manufactures, and sells generic pharmaceuticals.